T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Cencora
COR
$59.2B
| $27.7M | ﹤0.01% |
231,722
-1,655
| -0.7% | -$199K |
|
1202
Ameresco
AMRC
$1.47B
| $27.7M | ﹤0.01% |
473,283
-70,309
| -13% | -$4.63M |
|
1203
Quest Diagnostics
DGX
$26.1B
| $27.6M | ﹤0.01% |
190,166
-16,731
| -8% | -$2.45M |
|
1204
Perdoceo Education
PRDO
$1.99B
| $27.5M | ﹤0.01% |
2,605,173
-1,072,586
| -29% | -$12.1M |
|
1205
Sphere Entertainment
SPHR
$6.33B
| $27.5M | ﹤0.01% |
378,333
-119,312
| -24% | -$8.94M |
|
1206
FS Bancorp
FSBW
$326M
| $27.5M | ﹤0.01% |
793,437
-1,369
| -0.2% | -$47K |
|
1207
Diageo
DEO
$52.8B
| $27.4M | ﹤0.01% |
141,829
-438
| -0.3% | -$84.9K |
|
1208
Williams-Sonoma
WSM
$28.5B
| $27.3M | ﹤0.01% |
308,438
+3,424
| +1% | +$290K |
|
1209
Western Digital
WDC
$168B
| $27.3M | ﹤0.01% |
640,913
-9,790
| -2% | -$465K |
|
1210
Cincinnati Financial
CINF
$26.5B
| $27.3M | ﹤0.01% |
239,250
-4,307
| -2% | -$511K |
|
1211
American Vanguard Corp
AVD
$62.8M
| $27.3M | ﹤0.01% |
1,810,760
-256,299
| -12% | -$4.05M |
|
1212
ChargePoint
CHPT
$160M
| $27.1M | ﹤0.01% |
67,829
+65,804
| +3,250% | +$30.6M |
|
1213
Duolingo
DUOL
$6.74B
| $27.1M | ﹤0.01% |
+162,776
| New | +$24.7M |
|
1214
Emergent Biosolutions
EBS
$230M
| $27.1M | ﹤0.01% |
540,549
-13,487
| -2% | -$817K |
|
1215
Omnicom Group
OMC
$24.2B
| $27.1M | ﹤0.01% |
373,417
-7,153
| -2% | -$531K |
|
1216
Blackbaud
BLKB
$2.1B
| $27M | ﹤0.01% |
383,627
-160,113
| -29% | -$11.3M |
|
1217
Aaon
AAON
$7.23B
| $26.9M | ﹤0.01% |
618,501
-40,538
| -6% | -$1.76M |
|
1218
Genuine Parts
GPC
$18.7B
| $26.9M | ﹤0.01% |
222,047
-2,607
| -1% | -$325K |
|
|
PVBC
1219
DELISTED
Provident Bancorp
PVBC
| $26.9M | ﹤0.01% |
1,677,486
-2,645
| -0.2% | -$42.6K |
|
1220
Metropolitan Bank Holding Corp
MCB
$1.17B
| $26.8M | ﹤0.01% |
+318,152
| New | +$23.2M |
|
1221
Sana Biotechnology
SANA
$1.1B
| $26.7M | ﹤0.01% |
1,187,109
-3,090
| -0.3% | -$64.9K |
|
|
FOLD
1222
DELISTED
Amicus Therapeutics
FOLD
| $26.5M | ﹤0.01% |
2,777,248
+209,572
| +8% | +$2.14M |
|
1223
W.W. Grainger
GWW
$62.2B
| $26.5M | ﹤0.01% |
67,385
-1,300
| -2% | -$564K |
|
|
CVAC
1224
DELISTED
CureVac
CVAC
| $26.4M | ﹤0.01% |
483,371
+480,297
| +15,624% | +$28.9M |
|
1225
MeiraGTx Holdings
MGTX
$1.17B
| $26.4M | ﹤0.01% |
2,003,020
-3,345
| -0.2% | -$45.8K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.